British physician and microbiologist Alexander Fleming, discoverer of penicillin nearly 100 years ago, was the first to warn ...

LimmaTech vaccinates first participants in phase 1 study of Staphylococcus aureus vaccine candidate LBT-SA7: Zurich Tuesday, February 18, 2025, 13:00 Hrs [IST] LimmaTech Biologics ...

A new study reveals that diabetes significantly accelerates the emergence and spread of antibiotic-resistant Staphylococcus ...

Ondine’s innovative light-activated antimicrobial treatment has the potential to become the first FDA-approved nasal decolonization treatment for the prevention of surgical site infections. The ...

From February 2022 to February 2023, they collected (using cotton swabs) and genetically sequenced bacterial samples from six ...

Cumberland Pharmaceuticals' antibiotic Vibativ (telavancin) injection has gained approval from China’s National Medical ...

Researchers have proven that antibiotic-resistant strains of a harmful bacteria thrive in a diabetic infection environment.

The primary etiology of these infections is Staphylococcus aureus, over 60% of which is ... review discusses various topical antibiotic treatment options for uncomplicated skin infections ...

Acurx Pharmaceuticals’ DNA Polymerase IIIC Inhibitors receives Japanese patent: Staten Island, New York Thursday, February 20, 2025, 18:00 Hrs [IST] Acurx Pharmaceuticals, Inc., ...

The following is a summary of “Early cytokine signatures and clinical phenotypes discriminate persistent from resolving MRSA ...

Investigating Staphylococcus aureus – a leading cause of antibiotic resistance-associated infections and deaths – researchers ...

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Wednesday.